Afterward, up-regulation of EZH2 was also detected in endometrial carcinoma, anaplastic thyroid carcinoma, esophageal cancer, nasopharyngeal carcinoma, breast cancer, and gastric cancer (GC) [17–23]. The gene discussed is EZH2; the disease is breast carcinoma.